HOX gene expression in phenotypic and genotypic subgroups and low HOXA gene expression as an adverse prognostic factor in pediatric ALL
- 29 July 2010
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 55 (6), 1072-1082
- https://doi.org/10.1002/pbc.22749
Abstract
HOX genes play an important role in both normal lymphopoiesis and leukemogenesis. However, HOX expression patterns in leukemia cells compared to normal lymphoid progenitors have not been systematically studied in acute lymphoblastic leukemia (ALL) subtypes. The RNA expression levels of HOXA, HOXB, and CDX1/2 genes were analyzed by qRT-PCR in a cohort of 61 diagnostic pediatric ALL samples and FACS-sorted subpopulations of normal lymphoid progenitors. The RNA expression of HOXA7-10, HOXA13, and HOXB2-4 genes was exclusively detected in leukemic cells and immature progenitors. The RNA expression of HOXB6 and CDX2 genes was exclusively detected in leukemic cells but not in B-lineage cells at any of the studied developmental stages. HOXA3-4, HOXA7, and HOXB3-4 genes were differentially expressed between BCP-ALL and T-ALL subgroups, and among genotypically defined MLL/AF4, TEL/AML1, BCR/ABL, hyperdiploid and normal karyotype subgroups. However, this differential expression did not define specific clusters in hierarchical cluster analysis. HOXA7 gene was low expressed at the RNA level in patients with hyperdiploid leukemia, whereas HOXB7 and CDX2 genes were low expressed in TEL/AML1-positive and BCR/ABL-positive cases, respectively. In contrast to previous findings in acute myeloid leukemia, high HOXA RNA expression was associated with an excellent prognosis in Cox's regression model (P = 0.03). In MLL/AF4-positive ALL, lower HOXA RNA expression correlated with the methylation status of their promoters. HOX gene RNA expression cannot discriminate leukemia subgroups or relative maturity of leukemic cells. However, HOXA RNA expression correlates with prognosis, and particular HOX genes are expressed in specific genotypically characterized subgroups.Keywords
Funding Information
- MSMTVZ (MSM0021620813)
- GAČR (301/08/P532)
- IGA (NR9526)
This publication has 42 references indexed in Scilit:
- Leukemogenic transformation by HOXA cluster genesBlood, 2010
- Hox regulation of normal and leukemic hematopoietic stem cellsCurrent Opinion in Hematology, 2005
- HOXB6 overexpression in murine bone marrow immortalizes a myelomonocytic precursor in vitro and causes hematopoietic stem cell expansion and acute myeloid leukemia in vivoBlood, 2005
- The pathophysiology of HOX genes and their role in cancerThe Journal of Pathology, 2005
- Molecular interactions involved in HOXB4-induced activation of HSC self-renewalBlood, 2004
- Reduced Proliferative Capacity of Hematopoietic Stem Cells Deficient inHoxb3andHoxb4Molecular and Cellular Biology, 2003
- Hoxa9 Immortalizes a Granulocyte-Macrophage Colony-Stimulating Factor-Dependent Promyelocyte Capable of Biphenotypic Differentiation to Neutrophils or Macrophages, Independent of Enforced Meis ExpressionMolecular and Cellular Biology, 2000
- Overexpression of HOXA10 in Murine Hematopoietic Cells Perturbs both Myeloid and Lymphoid Differentiation and Leads to Acute Myeloid LeukemiaMolecular and Cellular Biology, 1997
- Overexpression of HOXB3 in Hematopoietic Cells Causes Defective Lymphoid Development and Progressive MyeloproliferationImmunity, 1997
- Differential expression of homeobox genes in functionally distinct CD34+ subpopulations of human bone marrow cells.Proceedings of the National Academy of Sciences of the United States of America, 1994